2-Fluorofucose

N/A

Report date: 2024/11/22 09:34:08
NME

Base Information

Drug Name2-Fluorofucose
Drug Alias NameSGD-2083SGN2FF2-fluorofucose peracetate2FF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFucosylation inhibitor
TargetsNot applicable
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSeagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeagen Inc
Active IndicationsN/A
Inactive IndicationsGastroesophageal Junction NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 

Other Information

ATC CodeN/A
Related LinksN/A